These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26786161)

  • 41. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Docosahexanoic acid modifies low-density lipoprotein receptor abundance in HepG2 cells via suppression of the LXRα-Idol pathway.
    Zhou Y; Guo Y; Zhuang X; Du Z
    Mol Med Rep; 2015 Mar; 11(3):2329-33. PubMed ID: 25394495
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of type 2 diabetes on the inducible degrader of LDL receptor.
    Lam S; Lui DTW; Shiu SWM; Wong Y; Tan KCB
    J Lipid Res; 2023 Jun; 64(6):100380. PubMed ID: 37094639
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nerve growth factor (NGF) and pro-NGF increase low-density lipoprotein (LDL) receptors in neuronal cells partly by different mechanisms: role of LDL in neurite outgrowth.
    Do HT; Bruelle C; Pham DD; Jauhiainen M; Eriksson O; Korhonen LT; Lindholm D
    J Neurochem; 2016 Jan; 136(2):306-15. PubMed ID: 26484803
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IDOL regulates systemic energy balance through control of neuronal VLDLR expression.
    Lee SD; Priest C; Bjursell M; Gao J; Arneson DV; Ahn IS; Diamante G; van Veen JE; Massa MG; Calkin AC; Kim J; Andersén H; Rajbhandari P; Porritt M; Carreras A; Ahnmark A; Seeliger F; Maxvall I; Eliasson P; Althage M; Åkerblad P; Lindén D; Cole TA; Lee R; Boyd H; Bohlooly-Y M; Correa SM; Yang X; Tontonoz P; Hong C
    Nat Metab; 2019 Nov; 1(11):1089-1100. PubMed ID: 32072135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adenovirus-mediated gene transfer of human lipoprotein lipase ameliorates the hyperlipidemias associated with apolipoprotein E and LDL receptor deficiencies in mice.
    Zsigmond E; Kobayashi K; Tzung KW; Li L; Fuke Y; Chan L
    Hum Gene Ther; 1997 Nov; 8(16):1921-33. PubMed ID: 9382958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CCC- and WASH-mediated endosomal sorting of LDLR is required for normal clearance of circulating LDL.
    Bartuzi P; Billadeau DD; Favier R; Rong S; Dekker D; Fedoseienko A; Fieten H; Wijers M; Levels JH; Huijkman N; Kloosterhuis N; van der Molen H; Brufau G; Groen AK; Elliott AM; Kuivenhoven JA; Plecko B; Grangl G; McGaughran J; Horton JD; Burstein E; Hofker MH; van de Sluis B
    Nat Commun; 2016 Mar; 7():10961. PubMed ID: 26965651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-translational regulation of the low-density lipoprotein receptor provides new targets for cholesterol regulation.
    Aldworth H; Hooper NM
    Biochem Soc Trans; 2024 Feb; 52(1):431-440. PubMed ID: 38329179
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-physiological overexpression of the low density lipoprotein receptor (LDLr) gene in the liver induces pathological intracellular lipid and cholesterol storage.
    Cichon G; Willnow T; Herwig S; Uckert W; Löser P; Schmidt HH; Benhidjeb T; Schlag PM; Schnieders F; Niedzielska D; Heeren J
    J Gene Med; 2004 Feb; 6(2):166-75. PubMed ID: 14978770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inducible degrader of LDLR: A potential novel therapeutic target and emerging treatment for hyperlipidemia.
    Yu Q; Zheng H; Zhang Y
    Vascul Pharmacol; 2021 Oct; 140():106878. PubMed ID: 34015522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mylip makes an Idol turn into regulation of LDL receptor.
    Lindholm D; Bornhauser BC; Korhonen L
    Cell Mol Life Sci; 2009 Nov; 66(21):3399-402. PubMed ID: 19688294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disruption of ldlr causes increased LDL-c and vascular lipid accumulation in a zebrafish model of hypercholesterolemia.
    O'Hare EA; Wang X; Montasser ME; Chang YP; Mitchell BD; Zaghloul NA
    J Lipid Res; 2014 Nov; 55(11):2242-53. PubMed ID: 25201834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonclinical Pharmacology/Toxicology Study of AAV8.TBG.mLDLR and AAV8.TBG.hLDLR in a Mouse Model of Homozygous Familial Hypercholesterolemia.
    Greig JA; Limberis MP; Bell P; Chen SJ; Calcedo R; Rader DJ; Wilson JM
    Hum Gene Ther Clin Dev; 2017 Mar; 28(1):28-38. PubMed ID: 28319445
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LDL Receptor Pathway Regulation by miR-224 and miR-520d.
    Salerno AG; van Solingen C; Scotti E; Wanschel ACBA; Afonso MS; Oldebeken SR; Spiro W; Tontonoz P; Rayner KJ; Moore KJ
    Front Cardiovasc Med; 2020; 7():81. PubMed ID: 32528976
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholesterol-Lowering Gene Therapy Counteracts the Development of Non-ischemic Cardiomyopathy in Mice.
    Muthuramu I; Amin R; Postnov A; Mishra M; Aboumsallem JP; Dresselaers T; Himmelreich U; Van Veldhoven PP; Gheysens O; Jacobs F; De Geest B
    Mol Ther; 2017 Nov; 25(11):2513-2525. PubMed ID: 28822689
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels.
    Goedeke L; Rotllan N; Canfrán-Duque A; Aranda JF; Ramírez CM; Araldi E; Lin CS; Anderson NN; Wagschal A; de Cabo R; Horton JD; Lasunción MA; Näär AM; Suárez Y; Fernández-Hernando C
    Nat Med; 2015 Nov; 21(11):1280-9. PubMed ID: 26437365
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA.
    Bjune K; Wierød L; Naderi S
    Sci Rep; 2018 Nov; 8(1):16174. PubMed ID: 30385871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liver X receptors agonists impede hepatitis C virus infection in an Idol-dependent manner.
    Zeng J; Wu Y; Liao Q; Li L; Chen X; Chen X
    Antiviral Res; 2012 Sep; 95(3):245-56. PubMed ID: 22713431
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proprotein convertase substilisin/kexin type 9 antagonism reduces low-density lipoprotein cholesterol in statin-treated hypercholesterolemic nonhuman primates.
    Liang H; Chaparro-Riggers J; Strop P; Geng T; Sutton JE; Tsai D; Bai L; Abdiche Y; Dilley J; Yu J; Wu S; Chin SM; Lee NA; Rossi A; Lin JC; Rajpal A; Pons J; Shelton DL
    J Pharmacol Exp Ther; 2012 Feb; 340(2):228-36. PubMed ID: 22019884
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.